Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

M&A
News

Deutsche Post Is Said To Join Bidding For Hillebrand

-Bloomberg

byBenzinga Newsdesk

August 9, 2021

1 minute read

-Bloomberg

Merck To Acquire Acceleron Pharma For $180/Share In Cash For An Approximate Total Equity Value Of $11.5B

By Benzinga Newsdesk

Today, 8:26 PM

Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Acceleron Pharma Inc. (NASDAQ:XLRN), a publicly traded biopharmaceutical company, today announced that the companies have entered into a definitive

MRK

El-Erian Says Credit Suisse-UBS Deal ‘Not Clean’ But Best Of Available Options

By Bhavik Nair

Today, 8:26 PM

Allianz chief economic adviser and noted economist Mohamed El-Erian reportedly said Credit Suisse Group AG’s (NYSE:CS) deal with…

The Green Organic Dutchman Q3 Revenue Grows 36% YoY, Here Are The Details

By Vuk Zdinjak

Today, 8:26 PM

The Green Organic Dutchman Holdings Ltd. (OTC: TGODF) (CSE:TGOD) released its financial results for the quarter ended September 30, 2022, revealing net revenues of CA$9.92 million ($7.38 million), a 36% increase from Q3 2021.

CSE:TGOD

News

Wave Life Sciences Reports Amendment To Central Nervous System Collab With Takeda: Allows For Co. To Advance, Partner On Its Central Nervous System Programs

By Benzinga Newsdesk

Today, 8:26 PM

Amendment to ongoing collaboration allows Wave to advance or partner CNS programs, including those using ADAR editing Takeda option to co-develop and co-commercialize late-stage CNS programs, including clinical programs

WVE

Deutsche Post Is Said To Join Bidding For Hillebrand

Related Posts

Merck To Acquire Acceleron Pharma For $180/Share In Cash For An Approximate Total Equity Value Of $11.5B

El-Erian Says Credit Suisse-UBS Deal ‘Not Clean’ But Best Of Available Options

The Green Organic Dutchman Q3 Revenue Grows 36% YoY, Here Are The Details

Wave Life Sciences Reports Amendment To Central Nervous System Collab With Takeda: Allows For Co. To Advance, Partner On Its Central Nervous System Programs